Pipeline
Elcelyx Therapeutics is developing safe first-in-class approaches to obesity-related metabolic disorders and weight management. The Elcelyx product candidates, NewMet for Type 2 diabetes and Lovidia for weight management, are composed of active pharmaceutical and dietary ingredients that have been safely used by consumers for decades. NewMet and Lovidia represent reduced-risk, near-term blockbuster opportunities in diabetes and weight management with longer-term opportunities in obesity and prediabetes.
